The overexpression of METTL3 in AML cells results in the methylation of c-MYC, BCL2 and PTEN mRNAs, which leads to the maintenance of HSCs and the overexpression of BCL2 and PTEN. Here, BCL2 is linked to acute myeloid leukemia.